Nuchev Pty Ltd (NUC) AI Stock Analysis

• Market Cap: AU$21.17M
• Dividend Yield: N/A
• Average Volume (3M): 7.76K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.87
• Revenue Growth: 102.21%
• EPS Growth: 69.47%
• Country: AU
• Employees: N/A
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): -0.02
• Shares Outstanding: 156,818,770
• 10 Day Avg. Volume: 3,027
• 30 Day Avg. Volume: 7,761
• PEG Ratio: 0.08
• Price to Book (P/B): 1.82
• Price to Sales (P/S): 0.89
• P/FCF Ratio: -5.19
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 45 Neutral
• Price Target: AU$0.16 ▲(30.00% Upside)
• Action: Upgraded Date: 02/28/26
• Date: Action: Upgraded 02/28/26

The score is held down primarily by weak financial performance—ongoing losses, negative ROE, and negative operating/free cash flow—despite strong revenue growth and low leverage. Technicals are supportive due to an upward trend above major moving averages, but overbought signals and a slightly negative MACD reduce confidence. Valuation is constrained by negative earnings (negative P/E) and no indicated dividend yield.

Positive Factors

Strong Revenue Growth

Sustained double‑digit top‑line growth indicates expanding product adoption and distribution reach. Over 2–6 months this supports scale benefits, stronger negotiating power with retailers/distributors, and a clearer pathway to leverage fixed costs toward eventual profitability.

Conservative Leverage

Low leverage provides durable financial flexibility: it reduces solvency risk, preserves capacity to fund working capital and inventory for growth, and lowers the probability of distress during investment in export expansion or marketing initiatives.

Niche Product & Multi-Channel Distribution

A differentiated goat‑milk formula niche plus diversified channels (retail, DTC, export) creates competitive moats: brand differentiation, channel mix optionality that supports higher‑margin direct sales, and reduced customer concentration risks across markets.

Negative Factors

Persistent Negative Profitability

Ongoing negative EBIT and net margins show the business has not yet converted sales into profits. Over time this impairs retained earnings, limits reinvestment from operating profits, and may force reliance on external capital to sustain growth initiatives.

Weak Cash Generation

Negative operating and free cash flows indicate the core business is not funding its growth. This creates durable liquidity pressure, constrains working capital for inventory and distribution, and heightens reliance on financing or dilution to support expansion.

Negative Return on Equity

A negative ROE signals that invested shareholder capital is not producing returns, suggesting inefficient capital allocation or early-stage losses. Over months this undermines shareholder value creation and can hinder access to equity financing on favorable terms.

Nuchev Pty Ltd Business Overview & Revenue Model

Company Description

Nuchev Pty Ltd (NUC) is an Australian-based company that specializes in the development and distribution of premium, goat milk-based nutritional products. Operating primarily in the infant formula and functional food sectors, Nuchev focuses on producing high-quality, natural alternatives to traditional cow's milk products. The company's core offerings include a range of infant formula, toddler milk, and other dietary supplements that cater to health-conscious consumers. Nuchev is committed to sustainability and ethical sourcing, ensuring that its products are not only nutritious but also environmentally friendly.

How the Company Makes Money

Nuchev Pty Ltd generates revenue primarily through the sale of its goat milk-based infant formula and related nutritional products. The company employs a direct-to-consumer sales model, alongside partnerships with retailers and distributors to expand its market reach. Key revenue streams include online sales through its own e-commerce platform and third-party retailers, as well as bulk sales to health food stores and supermarkets. Significant partnerships with health and wellness influencers and nutritionists also contribute to brand awareness and customer acquisition, driving sales growth. Additionally, Nuchev may benefit from strategic alliances with distributors that facilitate entry into international markets, thereby enhancing its revenue potential.

Nuchev Pty Ltd Financial Statement Overview

Summary

Despite strong revenue growth (45.28%), profitability remains weak with negative EBIT and net margins, negative ROE, and challenging cash generation (negative operating and free cash flows). Low leverage is a positive, but overall fundamentals are constrained by losses and cash flow pressure.

Income Statement

Nuchev Pty Ltd has shown significant revenue growth of 45.28% in the latest year, indicating strong sales momentum. However, the company is struggling with profitability, as evidenced by negative net profit margins and EBIT margins. The gross profit margin is moderate, but the persistent negative EBIT and net income highlight ongoing operational challenges.

Balance Sheet

The company's debt-to-equity ratio is low, suggesting conservative leverage. However, the return on equity is negative, reflecting the company's inability to generate profits from its equity base. The equity ratio is relatively stable, indicating a solid asset base, but the negative ROE is a concern for investors.

Cash Flow

Nuchev Pty Ltd's cash flow situation is challenging, with negative operating and free cash flows. The free cash flow growth rate is negative, and the operating cash flow to net income ratio is unfavorable, indicating cash flow issues. The company needs to improve its cash generation to support its operations and growth.

Breakdown	TTM	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021
Income Statement
Total Revenue	24.27M	22.94M	11.34M	8.79M	9.72M	10.90M
Gross Profit	7.17M	10.86M	3.63M	1.90M	2.78M	3.20M
EBITDA	-4.18M	-3.73M	-7.18M	-8.57M	-10.88M	-12.40M
Net Income	-4.58M	-3.82M	-7.32M	-8.81M	-11.11M	-13.27M
Balance Sheet
Total Assets	17.39M	17.39M	20.09M	15.32M	17.75M	28.31M
Cash, Cash Equivalents and Short-Term Investments	3.11M	3.61M	7.61M	7.49M	5.13M	14.53M
Total Debt	529.14K	392.63K	322.85K	284.14K	154.12K	286.33K
Total Liabilities	6.63M	6.16M	5.34M	2.51M	1.92M	1.62M
Stockholders Equity	10.76M	11.23M	14.75M	12.82M	15.83M	26.69M
Cash Flow
Free Cash Flow	-3.62M	-3.93M	-3.74M	-3.38M	-11.62M	-9.86M
Operating Cash Flow	-3.48M	-3.74M	-3.73M	-3.26M	-11.61M	-9.49M
Investing Cash Flow	-169.48K	-138.16K	-2.19M	-126.83K	-914.20K	411.90K
Financing Cash Flow	1.81M	-115.53K	6.06M	5.78M	-118.28K	14.16M

Nuchev Pty Ltd Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.12
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NUC, the sentiment is Positive. The current price of 0.12 is below the 20-day moving average (MA) of 0.13, below the 50-day MA of 0.13, and below the 200-day MA of 0.15, indicating a bullish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 75.73 is Negative, neither overbought nor oversold. The STOCH value of 77.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:NUC.

Nuchev Pty Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
MBH	54 Neutral	AU$37.18M	-2.03	-31.14%	―	-15.07%	29.45%
NUC	45 Neutral	AU$21.17M	-4.43	-29.43%	―	102.21%	69.47%
WNX	42 Neutral	AU$6.72M	-0.35	-184.71%	―	39.53%	49.99%
NOU	40 Underperform	AU$31.87M	-0.35	―	―	1.03%	-52.56%
AHF	40 Underperform	AU$26.88M	-5.25	-20.54%	―	13.92%	36.28%

Nuchev Pty Ltd Corporate Events

Nuchev Reaffirms Brand-Led Strategy in Half-Year Update

Nuchev Limited has reiterated its strategy of building trusted nutrition brands that families can rely on across multiple life stages, highlighting a disciplined focus on science-based product development and high product quality. The company underscored that consistent execution and responsible capital management are central to sustaining brand strength, driving repeat purchases and supporting long-term growth and value for stakeholders.

While specific financial figures for the half year to 31 December 2025 were not disclosed, the release positions Nuchev’s core pillars of brand trust, quality and execution as the key levers for future performance. This strategic emphasis is intended to reinforce the company’s market positioning in premium nutrition and signal a continued commitment to sustainable portfolio value in a competitive sector.

The most recent analyst rating on (AU:NUC) stock is a Sell with a A$0.12 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.

Nuchev lifts revenue but widens loss as investment in goat milk nutrition growth continues

Nuchev reported a 12% rise in half-year revenue to $12.4 million and higher gross profit, driven mainly by its Australian retail channel and supported by practitioner and international markets, despite timing variability in shipments to Vietnam and China. Gross margin eased to 46.2% and EBITDA loss widened to $2.1 million as the company continued to invest in marketing, brand development and organisational capability, remaining debt-free with $3.1 million in cash and a focus on working capital discipline.

Management emphasised that the larger statutory net loss of $2.34 million reflects its deliberate investment phase and the operating scale needed to support future growth. The company is prioritising stronger execution across channels, improving revenue quality and portfolio mix, and advancing new product development to position the business for sustainable profitability and long-term expansion in its core goat milk nutrition markets.

The most recent analyst rating on (AU:NUC) stock is a Sell with a A$0.12 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.

Nuchev Grows Revenue but Half-Year Loss Deepens as Asset Base Thins

Nuchev Limited has reported a 12% increase in revenue to $12.38 million for the half-year ended 31 December 2025, but its net loss after tax widened by 48.2% to $2.34 million, reflecting higher costs or investment outlays despite growing sales. The company did not declare any dividend for the period, and net tangible assets per share dropped from 6.17 cents to 4.29 cents year-on-year, indicating balance sheet pressure that may concern shareholders and highlight the need for improved profitability and capital efficiency.

The group’s net assets fell to $10.76 million while intangibles remained substantial at just over $4.09 million, underlining the importance of brand and other non-physical assets in its business model. With total shares on issue rising to 155.6 million and no changes in control of entities or new joint ventures, Nuchev’s latest half-year update points to a company still in a growth and investment phase, where sustained revenue gains will need to translate into earnings to strengthen investor confidence.

The most recent analyst rating on (AU:NUC) stock is a Sell with a A$0.12 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.

Nuchev Balances Softer Practitioner and International Sales With Solid Oli6 Performance and Positive Cash Flow

Nuchev reported second-quarter FY26 group sales revenue of $5.3 million, down 19% quarter-on-quarter and 13% year-on-year, with steady performance in its core Oli6 retail business offset by a sharp 48% quarterly decline in practitioner-channel revenue amid softer trading conditions. Despite weaker international sales due to shipment timing and delayed launches, the company generated a net operating cash inflow of $0.8 million, ended the quarter with $3.1 million in cash and no debt, and highlighted new product development across both consumer and practitioner lines as a key driver for future portfolio expansion and scale in ANZ and overseas markets.

The most recent analyst rating on (AU:NUC) stock is a Hold with a A$0.13 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.

Nuchev Director Increases Equity Stake via Incentive Plan Conversion

Nuchev Limited has disclosed a change in director Elizabeth Jean Smith’s interests following the exercise of unquoted share rights under the company’s Equity Incentive Plan, which was approved at the November 2024 AGM. Smith has received 278,750 ordinary shares in lieu of director fees valued at A$35,680, increasing her holding from no ordinary shares to 278,750, while her unquoted share rights decreased from 491,017 to 212,267, reflecting the vesting and conversion of incentives into equity and further aligning her interests with shareholders.

The most recent analyst rating on (AU:NUC) stock is a Hold with a A$0.12 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.

Nuchev Director Increases Shareholding Through Equity Incentive Plan

Nuchev Limited has announced a change in the interests of director Craig Silbery, following the exercise of unquoted share rights under the company’s Equity Incentive Plan. Silbery acquired 474,746 ordinary shares on 22 January 2026 through the conversion of vested share rights issued in lieu of directors’ fees, increasing his direct holding to 5,560,116 ordinary shares while reducing his unquoted share rights to 350,990. The transaction, approved under the company’s previously endorsed incentive framework, further aligns the director’s remuneration with shareholder interests and reflects ongoing use of equity-based compensation at the company.

The most recent analyst rating on (AU:NUC) stock is a Hold with a A$0.12 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.

Nuchev Director Increases Shareholding Through Equity Incentive Plan

Nuchev Limited has reported a change in director Ben Dingle’s interests following the exercise of unquoted share rights granted under the company’s Equity Incentive Plan in lieu of director fees. Dingle converted vested share rights valued at $61,325 into 479,102 ordinary shares, increasing his direct holding to 479,102 shares while maintaining an additional 37,853,680 shares held indirectly via 402339 Pty Ltd as trustee for the Whiti Trust, with the transaction occurring outside a closed period and reflecting ongoing alignment of director compensation with shareholder equity.

The most recent analyst rating on (AU:NUC) stock is a Hold with a A$0.12 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.

Nuchev Issues 1.23 Million New Shares Under Cleansing Notice

Nuchev Limited has issued 1,232,598 fully paid ordinary shares without a prospectus under the Corporations Act’s disclosure exemptions, confirming that it remains compliant with its continuous and financial reporting obligations and that there is no undisclosed price-sensitive information requiring release. The cleansing notice supports secondary trading of the newly issued shares by assuring investors that the company’s disclosure record is current, thereby facilitating capital management while maintaining transparency for shareholders and the broader market.

The most recent analyst rating on (AU:NUC) stock is a Hold with a A$0.12 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.

Nuchev Seeks ASX Quotation for 1.23 Million New Ordinary Shares

Nuchev Limited has applied to the ASX for quotation of 1,232,598 new ordinary fully paid shares, to be traded under its existing ticker NUC. The new securities, issued on 22 January 2026 following the exercise or conversion of existing options or convertible instruments, will increase the company’s free float and potentially enhance liquidity for shareholders, reflecting ongoing capital structure activity but without disclosing any broader strategic change in this notice.

The most recent analyst rating on (AU:NUC) stock is a Hold with a A$0.12 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.

Nuchev Names Veteran Executive Matt Parker as Interim CFO

Nuchev Limited has appointed Matt Parker as Interim Chief Financial Officer for six months starting 6 January 2026, bringing more than 25 years of financial and commercial leadership across FMCG, healthcare, manufacturing, retail and civil construction, including previous CFO and company secretary roles at several ASX-listed companies. The appointment signals a strengthening of Nuchev’s financial leadership as it continues to grow its nutritional and wellness portfolio across Australia, New Zealand, China and Vietnam, potentially supporting tighter financial governance and execution during a period of ongoing expansion in highly competitive consumer and practitioner-focused markets.

The most recent analyst rating on (AU:NUC) stock is a Sell with a A$0.12 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.

Nuchev Limited Reports Cessation of 4.3 Million Share Rights

Nuchev Limited has announced the cessation of 4,328,723 share rights due to the lapse of conditional rights that failed to meet specified criteria. This move reduces the company’s issued capital, potentially influencing its market operations and stakeholders while reflecting adjustments to its securities governance strategy.

The most recent analyst rating on (AU:NUC) stock is a Hold with a A$0.17 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.

Nuchev Limited Announces Director’s Interest Change

Nuchev Limited has announced a change in the director’s interest, specifically involving Meng Zhang, known as Leo. The company has issued 385,454 unquoted share rights to Zhang under its Equity Incentive Plan, in lieu of payment of directors’ fees amounting to $67,033.50. This move, approved at the recent AGM, reflects the company’s strategy to align director compensation with its equity performance, potentially impacting stakeholder perceptions and director engagement.

The most recent analyst rating on (AU:NUC) stock is a Hold with a A$0.17 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.

Nuchev Limited Updates Director Interest Notices and Enhances Compliance

Nuchev Limited announced changes in the interests of its directors due to the issuance of unquoted share rights in lieu of director fees, as approved in their annual meeting. This adjustment, initially omitted due to an administrative oversight, has prompted the company to enhance its transparency and compliance procedures. The changes reflect Nuchev’s commitment to maintaining robust governance practices, which is crucial for its stakeholders and market reputation.

The most recent analyst rating on (AU:NUC) stock is a Hold with a A$0.17 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.

Nuchev Limited Announces Successful AGM Results

Nuchev Limited announced the successful results of its Annual General Meeting, where all resolutions were passed by a poll. This outcome reflects strong shareholder support and may positively impact the company’s governance and strategic direction, reinforcing its position in the nutritional and wellness industry.

The most recent analyst rating on (AU:NUC) stock is a Hold with a A$0.17 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.

Nuchev Limited Outlines Strategic Priorities for Growth

Nuchev Limited has announced its strategic priorities to enhance its global presence and accelerate innovation. The company plans to strengthen its brand, drive sales growth through improved marketing, and maintain financial strength, which could positively impact its market positioning and stakeholder confidence.

The most recent analyst rating on (AU:NUC) stock is a Hold with a A$0.17 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.